C2E2 Member and UBC Faculty of Pharmaceutical Sciences assistant professor Mohsen Sadatsafavi will receive the 2018 Association of Faculties of Pharmacy of Canada (AFPC) New Investigator Research Award at an awards banquet to be held in June.
You are hereAbout
McGregor MJ, Cox MB, Slater JM, Poss J, McGrail KM, Ronald LA, Sloan J, Schulzer M. A before-after study of hospital use in two frail populations receiving different home-based services over the same time in Vancouver, Canada. BMC Health Serv Res. 2018 Apr 5;18(1):248.
Jan S, Laba T, Essue BM, Gheorghe A, Muhunthan J, Engelgau M. et al. Action to address the household economic burden of non-communicable diseases. The Lancet. 2018 April 4.
In Canada, as well as globally, chronic pulmonary disease (COPD) is a leading cause of morbidity and mortality. The disease—which causes inflammation of the lungs and makes it more difficult to breathe—is life-changing for patients and their families. In more severe cases, trips to the emergency room and regular hospital admissions are all too frequent, putting a great deal of strain on patients, families and the health care system.
Rachel Baker is Professor of Health Economics and Director of the Yunus Centre for Social Business and Health at Glasgow Caledonian University. Before moving to Glasgow in 2010, she worked at the University of Newcastle where she completed her PhD funded by the Medical Research Council (MRC) and her Postdoctoral Fellowship funded by the Economic and Social Research Council (ESRC).
Cragg A, Hau JP, Woo SA, Liu C, Doyle-Waters MM, Hohl CM. Risk factors for addiction among patients receiving prescribed opioids: a systematic review protocol. Syst Rev. 2017 Dec 28;6(1):265.
Tseng OL, Spinelli JJ, Gotay CC, Ho WY, McBride ML, Dawes MG. Aromatase inhibitors are associated with a higher fracture risk than tamoxifen: a systematic review and meta-analysis. Ther Adv Musculoskelet Dis. 2018 Apr;10(4) 71–90.
Background: In this paper, our aim was to systematically evaluate published evidence of bone fracture risk associated with tamoxifen and aromatase inhibitors in women aged 65 and under, and diagnosed with nonmetastatic breast cancer.
C2E2 Rounds are presented Mondays from 12:00 pm to 1:00 pm in room 700 of the VGH Research Pavilion, 828 West 10th Avenue, Vancouver, BC.